New Blood Test May Predict Alzheimer’s Disease Risk

Dr. Jeremy Koppel discusses a significant advancement in Alzheimer’s disease diagnosis. A newly developed blood test identifies abnormal protein build-ups crucial for recognizing the disease.

The test offers insights into diagnosing individuals already showing symptoms. This development promises to refine diagnostic processes.

Certain medical conditions could predict early-onset Alzheimer’s years before diagnosis, according to a Finnish study.

Researchers identified conditions like depression, vertigo, and headaches as more prevalent in the five years leading up to diagnosis. This finding may aid early detection efforts.

In the study, medical records from 407 early-onset Alzheimer’s patients were compared with 4,035 individuals of similar age and sex who were not diagnosed. The focus was on records from 15 years before diagnosis.

The average diagnosis age was 60. Early-onset refers to cases diagnosed before 65. These findings appeared in the journal Alzheimer’s & Dementia.

Specific conditions appeared significantly more in those diagnosed:

• Vertigo: 5.9% in diagnosed vs. 2.1% in non-diagnosed
• Depression: 5.7% vs. 2.3%
• Headache: 4.9% vs. 1.6%
• Stroke: 4.4% vs. 2.0%
• Alcohol-related disorders: 3.4% vs. 1.4%
• Brain disorders: 2.9% vs. 0.9%
• Thyroid disorders: 2.5% vs. 0.8%
• Epilepsy: 2.2% vs. 0.7%
• Delirium: 1.5% vs. 0.1%
• Ear, nose, and throat disorders: 5.2% vs. 2.9%

The study highlighted these conditions were most significant in the five years before an Alzheimer’s diagnosis. Patients also showed increased healthcare visits during this period, suggesting the emergence of symptoms.

Dr. Suvi-Johanna Krüger from the University of Oulu highlighted that Alzheimer’s-related changes begin 15-20 years before symptoms appear. Most research on late-onset Alzheimer’s has left early-onset Alzheimer’s less understood.

Study Limitations

This observational study cannot prove causality between the identified conditions and Alzheimer’s. According to Krüger, it’s unclear if these conditions cause or result from Alzheimer’s disease.

Factors such as genetics, lifestyle, and socioeconomic status might also influence outcomes. Larger studies could verify whether medical conditions relate to early detection.

For those experiencing persistent medical symptoms, including memory or cognition issues, consulting a healthcare provider is crucial.

Importance of Early Diagnosis

Krüger emphasizes the importance of early diagnosis for accessing treatment and support. Early knowledge aids in planning and accessing necessary services for patients and families.